As of January 22, 2025, Humacyte (HUMA) has a market cap of $0.59 billion USD. According to our data, Humacyte is ranked No.5914 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.59 B |
-9.11%
|
Dec 31, 2024 | $0.65 B |
77.82%
|
Dec 29, 2023 | $0.37 B |
34.60%
|
Dec 30, 2022 | $0.27 B |
-70.90%
|
Dec 31, 2021 | $0.93 B |
-28.71%
|
Dec 31, 2020 | $1.31 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Organovo
ONVO
|
$5.49 M |
0.000 M
|
USA
|
Vericel
VCEL
|
$2.89 B |
0.000 M
|
USA
|
MiMedx Group
MDXG
|
$1.32 B |
-0.000 M
|
USA
|
Axogen
AXGN
|
$0.83 B |
-0.000 M
|
USA
|
TELA Bio
TELA
|
$0.11 B |
0.000 M
|
USA
|
Avita Medical
RCEL
|
$0.22 B |
-0.000 M
|
USA
|
Repligen
RGEN
|
$9.35 B |
0.000 M
|
USA
|
Integra LifeSciences
IART
|
$1.92 B |
-0.000 M
|
USA
|
Mesoblast
MESO
|
$2.03 B |
0.000 M
|
Australia
|
Biolife Solutions
BLFS
|
$1.27 B |
0.000 M
|
USA
|
Market Cap | = | HUMA Stock Price | * | HUMA Shares Outstanding |
= | $4.59 | * | 0.13 B | |
= | $0.59 B |